Sionna Therapeutics, Inc.
SION
$6.46
-$0.08-1.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.60% | -31.01% | -0.80% | -12.23% | -9.62% |
| Total Depreciation and Amortization | 0.65% | 1.32% | -19.58% | 28.57% | -7.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.90% | 72.60% | 33.92% | 36.78% | 14.62% |
| Change in Net Operating Assets | 116.24% | -581.13% | -115.90% | 179.26% | -29.30% |
| Cash from Operations | -1.74% | -31.36% | -9.17% | 16.10% | -11.45% |
| Capital Expenditure | -- | -- | -134.48% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.50% | 8.90% | -1.71% | 199.76% | 83.53% |
| Cash from Investing | -13.50% | 9.88% | -2.22% | 199.38% | 83.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -55.76% | 33.39% | -15.96% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 28.13% | -- | -- | -- | -- |
| Cash from Financing | -60.43% | 14.10% | -15.96% | 732.69% | -100.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -100.04% | -36.06% | -22.60% | 123.61% | -192.88% |